FDX1 and cancer: For example, FDX1 or the cuproptosis signature serves as a prognostic indicator of various cancers, including bladder cancer [7], hepatocarcinoma [8], melanoma [9], and breast cancer [10], suggesting that its participation in cancer progression deserves a close investigation.